XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue
9 Months Ended
Sep. 30, 2023
Revenue [Abstract]  
Revenue

4.           Revenue

The Company recognized $16,000 of revenue for the three months ended September 30, 2023, and $389,000 of revenue for the nine months ended September 30, 2023. This revenue relates to recovery of clinical manufacturing costs associated with an investigator sponsored study managed by Cedars-Sinai Medical Center. There were no revenues recognized for the comparative periods in 2022.